The structure of KRASG12C bound to divarasib highlights features of potent switch-II pocket engagement
{{output}}
KRAS is the most frequently mutated oncogene in human cancer. In multiple types of cancer, a missense mutation at codon 12 substitutes a glycine for a cysteine, causing hyperactivation of the GTPase and enhanced MAPK signalling. Recent drug discovery efforts c... ...
